UCLA Health has performed its first single-port robotic lobectomy, a new technique that could reduce pain and ease recovery for lung cancer patients.
This approach allows surgeons to remove an entire lobe of the lung through a single small incision below the rib cage, avoiding sensitive nerves between the ribs.
A less invasive approach to lung cancer surgery
Lung cancer surgery has become less invasive over time, with surgeons increasingly using small incisions and robotic instruments instead of opening the chest to remove tumors.
Even these newer techniques can result in a painful recovery, partly because the instruments pass between the ribs, where sensitive nerves can become irritated.
How the technology works
During the procedure, the surgeon sits at a surgical console, controlling robotic instruments while viewing a magnified, three-dimensional image of the surgical area.
A robotic stapler designed for the single-port system allows them to divide and seal blood vessels, airways, and lung tissue directly from the console.
This technology enables the surgeon to perform complex operations through a single small incision, typically around 4 centimeters in length.
While the robot assists in the procedure, every movement is controlled by the surgeon, ensuring precision and flexibility during the operation.
Not all lung cancer patients are candidates for this approach. Factors such as tumor size, location, and the patient’s overall health are carefully evaluated to determine eligibility.
Patients with certain early-stage lung cancers that can be safely removed with surgery may be good candidates for single-port robotic lobectomy.
However, the decision is always individualized, prioritizing the safe and complete removal of the cancer over the number of incisions.
Related Post: Utah approves three AI health pilots
Recovery from single-port robotic lobectomy still requires time, as patients are undergoing a major lung operation.
Patients are encouraged to begin walking and doing breathing exercises soon after surgery to aid lung recovery and reduce complication risks.
A temporary chest tube is often used to drain air and fluid while the lung heals, and an individualized pain management plan is implemented to keep patients comfortable.
The length of hospital stay varies, depending on factors such as breathing, mobility, and pain management, as well as the timing of chest tube removal.
The introduction of single-port robotic surgery at UCLA builds on its well-established robotic thoracic surgery program.
UCLA’s thoracic surgeons work closely with medical oncologists, radiation oncologists, and other specialists to develop individualized treatment plans for patients.
The incision in UCLA’s first case was 4 centimeters, or about 1.6 inches, allowing for the removal of affected lung tissue and evaluation of surrounding lymph nodes.
Recovery and Patient Experience
Dr. Jay M. Lee, Surgical Director of the Thoracic Oncology Program at UCLA Health, emphasizes the importance of early mobility and breathing exercises to aid lung recovery and reduce complication risks.
A temporary chest tube often drains air and fluid during healing. Pain management is tailored to each patient, aiming to minimize discomfort and reduce opioid reliance.
Future Implications and Patient Impact
Dr. Lee envisions applying single-port robotic surgery to a broader range of lung and chest operations as instruments and techniques evolve. The goal is selecting the safest, most effective approach for each patient, minimizing surgery’s impact on their lives. UCLA’s first patient, walking three miles daily and pain-free less than three weeks after surgery, highlights this advancement’s potential to ease the experience for lung cancer patients.
Expert Insights on Single-Port Robotic Lobectomy
Not everyone with lung cancer is a candidate for this approach. Dr. Lee notes that factors like tumor characteristics and overall health determine suitability. This advancement, however, offers a promising option for those with specific early-stage cancers.
